These data demonstrate that primary resistance to EGFRi may be due to the autocrine production of HGF, which has been recently shown to occur in approximately 30% of colon cancers due to mutations in the HGF promoter region [12]. This evidence concerns the gene HGF and malignant colon neoplasm.